Canine c-reactive protein
About the parameter
C-reactive protein (CRP) is an acute phase protein. The serum level of CRP rises significantly in animals that suffer from different types of infection or inflammation, correlating with degree and activity of the causative disease. Measurements of serum CRP are used to aid the evaluation of the inflammation associated with infection, tissues damage and other clinical disorders.
Increased levels of CRP were described in dogs that suffered from pneumonia, pyometra, pancreatitis, parvovirus infection or traumatism. Dogs with an increased number of leukocytes had significantly higher CRP levels than dogs with noninflammatory leukograms. Increased CRP levels were also found in dogs with arthritis, thrombophlebitis or procitis. Moreover, they were observed in dogs infected with Bordetella bronchiseptica or Ehrlichia canis. This in-vitro test kit is designed to measure canine CRP in serum and plasma.
Recommended sample material is canine serum, canine heparinized plasma or canine EDTA plasma. Sample stability testing showed that canine CRP (in serum) was stable for 14 days
at 2 – 8 °C.
The test takes around 6 minutes.
10 – 200 mg/l (LOT specific)
Values up to 800 mg/l show no prozone effect.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser cCRP assay here: Eurolyser cCRP test evaluation
VT 0100 cCRP test kit (containing 16 tests)
VT 0101 cCRP test kit (containing 6 tests)
VT 1000 cCRP control kit (decision level)
7. February 2019
Sysmex Corporation, Japan and EUROLYSER, Austria to expand their co-operation in the Japan...» Read more...
4. December 2018
PSA (prostate specific antigen): Elevate prostatic diseases with Eurolyser’s new ass...» Read more...
21. November 2018
K+ Potassium: A new veterinary test for heart and lung muscle function assessment...» Read more...
26. September 2018